What is Polaryx Therapeutics, Inc. 's shares (basic)?

Polaryx Therapeutics, Inc. (PLYX) reported shares (basic) of 47.2M in Q1 2026.

What does shares (basic) mean?

The time-weighted average number of common shares outstanding during the period, used as the denominator for basic EPS calculations.

Polaryx Therapeutics, Inc. PLYX Shares (Basic)

Shares (Basic) at other companies

BioMarin PharmaceuticalsBMRN

192.5M+0.8%

Zevra Therapeutics, Inc.ZVRA

58.4M+8.0%

Eton Pharmaceuticals, Inc.ETON

27.3M+1.5%

XER

Xeris Biopharma Holdings, Inc.XERS

170.5M+11.9%

Relay Therapeutics, Inc.RLAY

179.8M+6.3%

PVL

Palvella TherapeuticsPVLA

13.1M+18.8%

Other financials

Income statement

See full

Operating income-$2.0M+61.2%

Net income-$2.5M+49.6%

EPS (diluted)-$0.05+54.5%

Balance sheet

See full

Cash & equivalents$3.1M+1,132%

Total equity$2.5M-41.5%

Total assets$3.5M—

Cash flow

See full

Operating cash flow-$2.1M-191%

Valuation

See full

Market cap$132.59M-86.9%

Returns & leverage

See full

Return on equity-1,209.8%—

Current ratio3.5×—

Where this comes from

Reported directly by Polaryx Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfSharesOutstandingBasic.

The official record: Polaryx Therapeutics, Inc. ’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Polaryx Therapeutics, Inc. 's shares (basic).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Polaryx Therapeutics, Inc. 's shares (basic)?: Polaryx Therapeutics, Inc. (PLYX) reported shares (basic) of 47.2M in Q1 2026.
What does shares (basic) mean?: The time-weighted average number of common shares outstanding during the period, used as the denominator for basic EPS calculations.